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We performed 12 loci MIRUeVNTR on 327 Mycobacterium tuberculosis (Mtb) isolates belonging to three
major spoligotypes MANU1, CAS1_Delhi and Beijing from Mumbai, western India and two proximal rural
locations. Complete allele and drug susceptibility data was available for 232 isolates. These included 143
MANU1 (ST100), 65 CAS1_Delhi (ST26) and 24 Beijing (ST1) isolates. Of the 232 isolates, 26 were rural
consisting 6 CAS1_Delhi and 20 MANU1 isolates.
Using eBURST multi-locus sequence typing (MLST), cluster analyses was performed for each of the
spoligotypes and drug susceptibility proﬁles. MANU1 MLST consisted of 90 related isolates (clustered and
grouped) and 53 singletons; CAS1_Delhi MLST consisted of 44 related isolates and 21 singletons; Beijing
MLST consisted of 10 related isolates and 14 singletons. Although the number of related isolates were
different in MANU1 (63%), CAS1_Delhi (68%) and Beijing (42%) clusters, it was not statistically signiﬁcant.
Furthermore, it was observed that while MANU1 and CAS1_Delhi singletons (n ¼ 74) had only 12 (16%)
MDR isolates, the Beijing MLST had 8/14 (57%) MDR singleton isolates.
Phylogenetic ananlysis using minimum spanning tree (MST) and a UPGMA radial tree revealed MANU1
had the largest number of nodes as compared to the CAS1_Delhi and Beijing spoligotypes. Additionally
the CAS isolates were more homogeneous than the MANU1 isolates.
The 12 loci MIRUeVNTR was used to provide greater discrimination than spoligotyping, but 6 of the 12
loci provided less than 50% discriminatory power. The highest discrimination was achieved using locus
26 (80%). Our results concur with recent reports that the most discriminatory MIRUeVNTR combination
varied across different lineages. The results also highlight the need for more robust genetic markers for
studying the transmission of Mtb in endemic regions like India.
 2012 Elsevier Ltd. Open access under CC BY-NC-ND license. 1. Introduction
Mycobacterium tuberculosis (Mtb) the etiological agent of tuber-
culosis (TB), is responsible for maximummortality by an infectious
disease globally.1 One of the oldest know pathogens, it is believed to
have evolved from a common progenitor about 15,000e20,000
years ago,2 the disease being documented in Egypt, India and
China as early as 5000, 3300 and 2300 years ago respectively.3
The evolution of such an ancient pathogen has been studied
using various markers, which deﬁne the diversity, phylogeny and
transmission of TB.4e10 However the utility of each of the markers
has been limited because of their diversity in different
populations.11,12
One marker used for genotyping Mtb is, the mycobacterial
interspersed repetitive units (MIRU), which occur in variable-NC-ND license. number tandem repeats (VNTR) consisting of multiple loci
scattered throughout the genome. MIRUeVNTR are believed to
be reminiscent of human microsatellites which are often hyper-
variable and may have an evolutionary function. Comparative
sequence analysis of strains H37Rv, CDC1551,M. bovis strain AF212/
97, and 31 Mtb clinical isolates identiﬁed 41 MIRUs. Five exact
tandem repeats (ETR-A to ETR-E) previously used as a genotyping
tool, were also included in the 41 MIRUs.13 Various combinations of
MIRUeVNTR loci have been used to ﬁnd the most discriminatory
and phylogenetically informative set of loci.14 In an effort to attain
maximum discrimination three sets of MIRUeVNTR were formu-
lated: 12 loci,8 15 loci and 24 loci.12 These sets of MIRUeVNTR are
analyzed using multiple locus vntr analysis (MLVA) andmulti-locus
sequence typing (MLST).
MIRUeVNTR (24 loci) analysis of Mtb clinical isolates in
a tertiary hospital in Mumbai reported a clonal population of Mtb
from multiple lung cavities.15 Studies from other regions of India
have reported moderate to high discrimination of predominant
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and QUB-4156c).16,17 All studies from the region have used
MIRUeVNTR as a secondary ﬁngerprinting technique either to
discriminate large spoligotype clusters or for phylogenetic analysis.
In this study, 12 loci MIRUeVNTR has been used to discriminate
the previously reported three largest spoligotype clusters: MANU1
(ST100), CAS1_Delhi (ST26) andBeijing (ST1).18 The cohort belonged
to the TB endemic cosmopolitan locale of Mumbai, in western India
with a high proportion of multi-drug resistance (MDR).19Whilst the
high proportion of MANU1 was noted to be typical for the region of
western India, CAS, predominantly found in northern India20,21 was
also recorded along with Beijing, which like other India based
studies20was recorded in lower proportion. The Beijing strainswere
also found to be associated with MDR.22 Although spoligotyping
yielded a high discrimination of 92%,22 the inherent low discrimi-
nation ascribed to the technique made it necessary to use
a secondary ﬁngerprinting technique.23 We thus used MIRUeVNTR
to distinguish the three largest spoligotype clusters which initially
formed 39% of the cohort.22
2. Materials and methods
2.1. Study population
The study was part of a larger epidemiological project assessing
transmission of MDRTB in Mumbai, in a population endemic for TB,
between April 2004 and August 2007.19,22 The study consisted of
two cohorts: urban and rural. The urban cohort consisted of new
pulmonary TB cases from four centrally located municipal wards
characterized by a high sputum-positive case load. Cumulatively
the four wards covered 38 DOTS (Directly Observed Therapy Short
Course) centers with a population of 3 million. The rural cohort
consisted of new pulmonary TB patients sampled from two rural TB
units, located 250 and 280 km fromMumbai, covering a population
of 860,000. This facilitated studying spoligotypes from the rural
cohort which, as opposed to Mumbai, had a more homogeneous
ethnic population comprising of an indigenous community with
little or no migration from other parts of India. Unlike the rural
cohort, the Mumbai region had a much smaller indigenous ethnic
population and included a large migrant population from other
parts of India .We could thus compare strain diversity in a homog-
enous (rural) and cosmopolitan (Mumbai, urban) cohort in a region
of west India. Additionally there exists a movement of people from
these rural areas to Mumbai, in the form of unskilled industrial
labour, which provided the opportunity to study the transmission
of TB strains between the two locations.
The samples included in the current study for the MIRUeVNTR
genotyping were recruited based on inclusion criteria described
earlier.19,22 Brieﬂy, 833 new cases of pulmonary TB accessing the
revised national TB program (RNTCP) were included based on
inclusion criteria: (i) smear-positivity, (ii) age 15e70 years, (iii)
residency in Mumbai or respective rural area for at least 3 years
immediately prior to diagnosis and (iv) residency in the same area
as the health posts where treatment was sought. Patients with
a past history of TB or anti-tuberculous therapy prior to the current
episode, as determined through interview and scrutiny of district
TB registers and patients defaulting during therapy were excluded.
Patients were recruited after obtaining written informed consent.
Clearance for this study was obtained from the Foundation for
Medical Research (FMR) Institutional Ethics Committee
(20.07.2001/01). MIRUeVNTR was performed on the isolates from
the 220 MANU1 (ST100), 77 CAS1_Delhi (ST26) and 30 Beijing
((ST1) isolates) as per earlier report.22 While the study had also
reported EAI5 as the fourth largest spoligotype, MIRUeVNTR was
not performed on those isolates because the EAI5 cluster grew aftercompletion of MIRUeVNTR experiments at the Institute of Infec-
tious Diseases and Molecular Medicine (IIDMM), University of Cape
Town (UCT). Furthermore CAS1_Delhi was the only CAS variant
from the published cohort22 that was studied here as the other CAS
variants did not build into large clusters.
2.2. Sample processing and culture
Sputum samples were collected in CPC-NaCl vials as previously
described.19 These samples were then concentrated by Petroff’s
method.24 The concentrated samples were inoculated onto Low-
enstein Jensen (LJ) Slants (Hi-Media, India) and incubated at 37 C
until growth was observed.
2.3. Drug Susceptibility testing (DST)
The DST of samples from the same cohort were performed and
reported earlier.19 Drug susceptibility proﬁles were classiﬁed into 4
groups: (a) drug susceptible (DS): susceptible to isoniazid (H),
rifampicin (R), ethambutol (E) and pyrazinamide (Z); (b) mono-
resistant: resistant to H or R or E or Z; (c) polyresistant: resistant to
more than 1 of H, E, R and Z but not simultaneously resistant to H
and R; (d) MDR: resistant to at least H and R.
2.4. MIRUeVNTR
Mtb colonies were recovered from LJ slants and re-suspended in
1M tris-ethylene diamine tetra-acetic acid (EDTA) buffer (pH 8.0)
using a bacteriological loop. Deoxy-ribonucleic acid (DNA) was
extracted using previously described methods.25,26 Twelve loci
MIRUeVNTRwas performed using themethod described by Supply
et al.8
Brieﬂy, the procedure comprised of two steps:
a PCR ampliﬁcation
The 12 loci studied were: locus 2, 4, 10, 16, 20, 23, 24, 26, 27, 31,
39 and 40. Since 12 MIRUeVNTR loci were studied, four triplex PCR
runs were performed for each sample. The multiplex PCRs were
performed in 96-well PCR plates using the HotStartTaq DNA poly-
merase kit (Qiagen, Hilden, Germany). For each multiplex mixture,
one primer of each oligonucleotide pair was tagged with a different
ﬂuorescent dye (NED, FAM and Hex) from Applied Biosystems, USA.
The thermal-cycler programs for the four multiplex reactions were
identical. The PCRs were carried out starting with a denaturing step
of 15 min at 95 C, followed by 40 cycles of 1 min at 94 C, 1 min at
59 C, and 1 min 30 s at 72 C. The reactions were terminated by
incubation for 10 min at 72 C. Negative controls consisted of the
PCR performed on reaction mixtures lacking mycobacterial DNA.
b Genotyping
The PCR products were then run on an ABI3100 sequencer on the
fragment analysis run module (genetic analyzer) for a run time of
40 min. The samples were run for 5.5 h at 3000 V, 2400 scans per h,
and 51 C using the D ﬁlter. The sizes of the PCR fragments were
estimated using the GeneScan and Genotyper software packages
(PE Applied Biosystem, USA). The assignment of the various alleles
was based on the corresponding expected sizes of the PCR products
for the 12MIRUeVNTR loci, calculated from the data of Supply et.al.
2000.13 Size tolerances of 4 and 6 bp were ﬁxed for PCR frag-
ments belowand above 500 bp, respectively,with an offset of1 bp.
MIRUeVNTR PCR and genetic analyzer runs were performed at
IIDMM, UCT. MIRUeVNTR proﬁles which could not be read due to
lack of peaks or multiple peaks were excluded from analysis.
Table 2
Hunter Gaston diversity index (HGDI) for each MIRUeVNTR locus.
Sl.No. Locus MANU1 CAS1_Delhi Beijing Total
1 MIRU02 0.07 0.06 0.00 0.06
2 MIRU04 0.16 0.15 0.16 0.16
3 MIRU10 0.69 0.73 0.61 0.72
4 MIRU16 0.55 0.57 0.49 0.58
5 MIRU20 0.07 0.00 0.00 0.04
6 MIRU23 0.28 0.32 0.23 0.29
7 MIRU24 0.26 0.14 0.16 0.22
8 MIRU26 0.82 0.77 0.77 0.80
9 MIRU27 0.12 0.00 0.16 0.09
10 MIRU31 0.58 0.44 0.49 0.53
11 MIRU39 0.47 0.33 0.37 0.42
12 MIRU40 0.43 0.57 0.42 0.47
Highlighted cells represent the six most discriminatory loci.
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three positive controls (DNA from H37Rv). Ten percent (33/327)
samples were repeated thrice as a part of internal quality control.
2.5. Data management and analysis
All patient data was entered andmaintained using SPSS ver. 19.0
(SPSS Inc, USA). Analyses were done using SPSS andMicrosoft Ofﬁce
Excel ’97 (Microsoft Corporation, USA). Multi-Locus Sequence
Typing (MLST) was performed using eBURST v.3 (http://eburst.mlst.
net/default.asp).27,28 Webtools available at http://www.miru-
vntrplus.org16,29 were used to plot the minimum spanning tree
(MST) and the phylogenetic radial tree using unweighted pair group
method with arithmetic mean (UPGMA).
Genetic diversity of each loci was calculated as the Hunter
Gaston diversity index (HGDI) using the formula described by
Hunter and Gaston.30 Associations between different conditions
were calculated using chi-square analysis with a conﬁdence
interval of 95% using SPSS.
3. Results
Spoligotyping of 833 isolates yielded three major strain clusters
(N ¼ 327): MANU1 (220), CAS1_Delhi (77) and Beijing (30).22
On performing 12 loci MIRUeVNTR on 327 isolates from the
three major spoligotype clusters, complete allele and DST data was
available for 232 isolates. These included 143 MANU1 (ST100), 65
CAS1_Delhi (ST26) and 24 Beijing (ST1) isolates (Supplementary
S1). The 232 isolates contained 26 rural samples consisting 20
MANU1 and 6 CAS1_Delhi isolates. (Supplementary ﬁle S1,Table 1).
Of the 95 (77 MANU1, 12 CAS1_Delhi, 6 Beijing) isolates for
which MIRUeVNTR could not be determined, 12 (11 MANU1 and 1
CAS1_Delhi) showed mixed peaks and 83 (66 MANU1, 11 CAS1_-
Delhi, 6 Beijing) had incomplete allelic information in at least 1 loci.
MIRU 26 was found to be most discriminatory for all three
spoligotypes. The least discriminatory locus for ST100, ST26 and
ST1 was locus 27, 24 and 2 respectively. Additionally locus 27 which
was the least informative in MANU1 isolates was found to be
moderately discriminatory for CAS1_Delhi and Beijing isolates (S1,
Table 2).
Using eBURST MLST, cluster analyses was performed for each of
the spoligotypes and drug susceptibility proﬁles. The MANU1MLST
consisted of 112 isolates (31 isolates in clusters) and ﬁve groups.
The largest group consisting of 46 isolates, and the predictedTable 1
Distribution of spoligotypes in different drug susceptibility proﬁles and sampling
areas.
Drug Susceptibility Spoligotype Total
CAS1_Delhi MANU1 Beijing
DS Urban 26 46 5 77
Rural 3 5 0 8
Total 29 51 5 85
Monoresistant Urban 4 32 3 39
Rural 0 5 0 5
Total 4 37 3 44
MDR Urban 14 23 14 51
Rural 2 6 0 8
Total 16 29 14 59
Poly Urban 15 22 2 39
Rural 1 4 0 5
Total 16 26 2 44
Total Urban 59 123 24 206
Rural 6 20 0 26
Total 65 143 24 232
DS, drug susceptible; MDR, multi-drug resistance; Poly, polyresistance.founder was isolate number 109 (Figure 1A, Table 3). Of the 143
MANU1 isolates, 53 (37%) were singletons. The CAS1_Delhi MLST
consisted of 55 isolates (10 isolates in clusters) and 2 groups. The
largest group consisted of 32 isolates and the predicted founder
was isolate number 55 (Figure 1B, Table 3). Twenty one (32%) of the
65 CAS1_Delhi isolates were singletons. The Beijing MLST consisted
of 19 isolates (5 isolates in clusters) and 1 group. The predicted
founder of the group was sample number 125 (Figure 1C, Table 3).
Of the 24 Beijing isolates, 14 (58%) were singletons.
eBurst was also used to perform MLST of isolates with different
drug resistance proﬁles. Of the 85 DS isolates, 77 were plotted on
theMLST diagram (8 were clustered), with 7 groups, the largest one
containing 29 isolates wherein isolate number 53was the predicted
founder. Thirty four (40%) of the 85 DS isolates were singletons
(Figure 2A, Table 3). Thirty seven monoresistant isolates formed
a MLST diagram (7 were clustered) consisting of 2 groups. The
largest group consisted of 18 isolates and the predicted founder was
isolate number 169 (Figure 2B, Table 3). Of the 44 monoresistant
isolates 17 (39%) were singletons. The 44 polyresistant isolates
included 8 isolates in clusters and 36 isolates forming an MLST tree
consisting 3 groups with the largest group of 8 isolates being pre-
dicted to be founded by isolate number 54 (Figure 2C, Table 3). Of
the 44 polyresistant isolates, 22 (50%) were singletons. Forty nine of
the 59 MDR isolates formed the MLST tree (10 isolates were clus-
tered) consisting of 6 groups, of which the largest group contained
11 isolates with isolate number 223 as the predicted founder. Of the
59 MDR isolates, 26 (44%) were singletons (Figure 2D, Table 3).
Since the eBURST uses single allele difference for calculating
genetic distance, we also used MST (Supplementary ﬁle S2) and
UPGMA radial tree (Figure 3) to determine the phylogeny of the
isolates based on spoligotype and MIRUeVNTR. In the radial tree
we observed that MANU1 had the largest number of nodes as
compared to the CAS and Beijing spoligotypes. Additionally the CAS
spoligotypes were more homogeneous than the MANU1 isolates.
The Beijing isolates were the most homogeneous with the least
number of nodes and longest branch lengths (Figure 3).
While the UPGMAmay bemisleading due the assumption of the
nearest ancestor, it still yielded the differential clonal nature of the
three spoligotypes. The Beijing isolates were found to be most
clonal with least genetic distances in the branches while the
MANU1 isolates with longer branches reﬂected the greater diver-
gence in the spoligotype.
Although the 12 loci MIRUeVNTR was used to provide greater
discrimination than spoligotyping, yet 6 of the 12 loci provided less
than 40% discriminatory power. The highest discrimination was
achieved using locus 26 (80%) (Table 2). However, on combining
spoligotype and MIRUeVNTR a discriminatory power of greater
than 98% was attained, which was greater than the gold standard
obtained using IS6110 RFLP.
Figure 1. MLST of 3 spoligotypes: ST100, ST26 and ST1.
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The study reports 12 loci MIRUeVNTR of largest number of
clinical Mtb isolates (232) yet reported from the region. The aim of
performing the MIRUeVNTR was to discriminate clustered spoli-
gotypes reported earlier.22 While the study also reported EAI5 as
the fourth largest spoligotype, MIRUeVNTR was not performed on
those isolates because the EAI5 cluster grew after completion of
MIRUeVNTR. MIRUeVNTR of EAI5 isolates could not be performed
at end of the study due infrastructural constraints at FMR. Addi-
tionally the choice of spoligotypes for MIRUeVNTR analysis was
based on the predominance of MANU1, CAS1_Delhi and Beijing
spoligotypes in the region reported till the beginning of the
study.18,31 The results additionally highlighted the strengths and
weakness of present molecular ﬁngerprinting techniques used inTable 3
Distribution of isolates in MLST.
MLST group N Clustered (C) Grouped (G) Related
(C þ G)
Singletons
MANU1* 143 31 59 90 53
CAS1_Delhi* 65 10 34 44 21
Beijing* 24 5 5 10 14
DSy 85 8 43 51 34
Monoresistanty 44 7 20 27 17
Polyresistanty 44 8 14 22 22
MDRy 59 10 23 33 26
Multi-locus sequence typing (MLST) plotted using eBURST v3.0.
* eBURST MLST in Figure 1.
y eBURST MLST in Figure 2.TB research. As observed in earlier studies,32 we found that spoli-
gotyping along with MIRUeVNTR provides maximum discrimina-
tion, which is desirable in epidemiological studies. The lack of
complete proﬁling for all isolates was found to be a major handicap
in analysis. All incomplete proﬁles displayed a lack of allelic infor-
mation in less than 4 loci, even after repeated trials. It was also
observed that half of the loci studied were highly conserved across
the cohort. Although this facilitated the rooting of the phylogeny, its
use remains limited in tracking transmission. Additionally, isolates
were excluded from analysis due to lack of allelic information in
some loci (MIRU02, MIRU26, MIRU10). This poses a shortcoming in
the technique which has also been reported elsewhere33 and needs
to be researched further.
While the rural cohort was considered more homogenous and
was also reported to have more MANU1 isolates and no Beijing
isolates,22 its MIRUeVNTR proﬁles were found to be linked with
urban isolates. While this may be attributed to transmission
through daily movement of people between the two locations, it
may also be due to homoplasy.34
While the number of isolates clustered or linked by MLST were
different in MANU1 (63%), CAS1_Delhi (68%) and Beijing (42%)
clusters, it was not statistically signiﬁcant. Furthermore, it was
observed that while MANU1 and CAS1_Delhi singletons (n ¼ 74)
had only 12 (16%) MDR isolates, the Beijing MLST had 8/14 (57%)
MDR singleton isolates. The higher number of MDRs in Beijing
singletons could be indicative of the evolutionary adaption of the
Beijing strain in a allopatric population during which it accumu-
lates different drug resistance mutations which may be more ﬁt in
the new population.35 Alternatively, the difference may also be due
to the fewer number of Beijing isolates in the cohort.
Figure 2. MLST of 4 drug susceptibility proﬁles.
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any genotypic linkage, which was also noticed in the lack of
epidemiological linkage between patients (data not shown). While
the DS and MDR isolates showed similar proportions of related
(grouped and clustered) isolates (60% and 56% respectively), the
MLSTof the DS had a larger linked group than theMDR. This may be
indicative of greater mutation rates in MDR isolates.Figure 3. UPGMA Radial Tree using spoligotypes and MIRUeVNTR of 232 isolates.The radial phylogenetic tree generated fromthe232MIRUeVNTR
proﬁles using UPGMA showed that while the CAS and Beijing
genotypes had lower genetic distances between the isolates,
MANU1 was found to show maximum discrimination. The MST of
the isolates revealed that MANU1 may be related to the Beijing
genotype. This observation is contradictory to reports of Beijing and
CAS1_Delhi being "modern" strains and MANU1 being an "ances-
tral" strain.17,36 However, the three spoligotypes (ST1, ST26 and
ST100) have been shown to belong to the same principal genetic
group.37 Additionally a recent study also reported MANU1 and
Beijing to be linked in an MST plotted using 12 loci MIRUeVNTR.38
Furthermore though Thomas et al.36 reported MANU1 as ancestral
andCASasmodern strains, it also reported a commonpncAmutation
between MANU1 and CAS. Thus our current understanding of the
clades ofMtb is insufﬁcient to determine the position of MANU1 in
the global Mtb phylogeny. Earlier studies22,36 along with the obser-
vation in this report indicate MANU1 to be present in deﬁned
geographical areas. AlternativelyMANU1may be amisclassiﬁcation
due to mixed infection of LAM and EAI strains.39 Of the 77 MANU1
isolates for whichMIRUeVNTR could not be determined, 11 isolates
were excluded due to presence of mixed peaks. In the study all
isolates which producedmixed peaks in GeneScan, were inferred to
have inconclusive MIRUeVNTR proﬁles and were not included in
analyses. Additionally we performed spoligotyping of single colony
isolates from3MANU1 samples (withoutmixedpeaks) and found all
single colonies to be MANU1 (data not shown).
The large number of singletons observed in the different MLSTs
is indicative of the high discriminatory power of MIRUeVNTR.
However the high discrimination could be mainly attributed to 6
loci, since the other 6 had very low HGDIs. This highlights the
A. Chatterjee, N. Mistry / Tuberculosis 93 (2013) 250e256 255variable effectiveness of present day genetic markers. Additionally,
as evinced from recent reports,14 it is possible that a different set of
MIRU loci (for example: vntr2163b, vntr1955, vntr4052, vntr2461,
vntr2165, vntr4156, vntr3690, vntr2163b) may have yielded better
results in the cohort.
The results from our study may be added to global Mtb
phylogeny to facilitate a better understanding of Mtb evolution.
Additionally the results also indicate the need for better universal
markers as well as lineage and region speciﬁc markers.
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